FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role (role) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Etoposide 50 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Etoposide 100 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing ruxolitinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ruxolitinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ruxolitinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ruxolitinib (as ruxolitinib phosphate) 10 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ruxolitinib 20 milligram/1 each conventional release oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ruxolitinib 15 milligram/1 each conventional release oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ruxolitinib 25 milligram/1 each conventional release oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Some
Ruxolitinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Romidepsin only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Romidepsin 10 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing romidepsin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only romidepsin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing romidepsin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing sorafenib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Sorafenib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only sorafenib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Sorafenib (as sorafenib tosylate) 200 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing sorafenib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing regorafenib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only regorafenib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Regorafenib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Regorafenib 40 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Regorafenib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Raltitrexed only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Raltitrexed only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing raltitrexed (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Raltitrexed 2 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing raltitrexed in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only streptozocin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing streptozocin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only streptozocin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Streptozocin 1 g powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing streptozocin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing sunitinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Sunitinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Sunitinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely sunitinib (as sunitinib malate) 25 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely sunitinib (as sunitinib malate) 12.5 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Sunitinib (as sunitinib malate) 50 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Sunitinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only panobinostat (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing panobinostat (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only panitumumab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Panitumumab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely panitumumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing panitumumab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Panitumumab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing pentostatin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only pentostatin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only pentostatin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pentostatin 10 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pentostatin-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pegaspargase only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only pegaspargase in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely pegaspargase 750 unit/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing pegaspargase (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pegaspargase-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pemetrexed only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Pemetrexed-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only pemetrexed in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely pemetrexed (as pemetrexed disodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely pemetrexed (as pemetrexed disodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing pemetrexed (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only vandetanib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing vandetanib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely vandetanib 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Vandetanib 300 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing vandetanib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Vandetanib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only valrubicin in intravesical dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Valrubicin-containing product in intravesical dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing valrubicin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Valrubicin only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely neratinib (as neratinib maleate) 40 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Neratinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Neratinib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing neratinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing neratinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only nelarabine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing nelarabine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nelarabine only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing nelarabine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Brentuximab vedotin-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Brentuximab vedotin only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing brentuximab vedotin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Brentuximab vedotin only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely necitumumab 16 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Necitumumab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only necitumumab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Fedratinib (as fedratinib hydrochloride) 100 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only blinatumomab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only blinatumomab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing blinatumomab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing blinatumomab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing bortezomib in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only bortezomib in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing bortezomib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only bortezomib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some

Start Previous Page 5 of 17 Next End

This concept is not in any reference sets

Back to Start